EFFECTIVENESS OF TREATMENT CHRONIC SINUSITIS IN CHILDREN WITH THE PARISINUS 2 INHALER
DOI:
https://doi.org/10.37219/29zbj828Keywords:
chronic sinusitis, children, Parisinus 2 inhaler, aerosol therapy, inflammation, mucociliary clearance, physiotherapyAbstract
The clinical features, pathogenesis, and efficacy of local aerosol therapy using the Parisinus 2 inhaler for chronic sinusitis in children are discussed. The results of a clinical study involving 60 pediatric patients aged 7-14 years showed that therapy using the Parisinus 2 inhaler rapidly alleviated symptoms of inflammation, restored mucociliary clearance, and prolonged remission. This method was found to be safe, effective, and physiologically acceptable in children.
References
1. Shermatov AB, Khodjaev NR. Modern physiotherapy methods in otorhinolaryngology. Tashkent: TTA publishing house, 2021.
2. Anamika A, Chakravarti A, Kumar R. Atopy and quality of life in pediatric chronic rhinosinusitis. Am J Rhinol Allergy. 2019 Sep;33(5):586-590. doi: 10.1177/1945892419854266.
3. Abduvokhidova Sh.M. Complex therapy for chronic sinusitis in children. Journal of Medicine, 2022.
4. Mainz JG, Schien C, Schiller I, Schädlich K, Koitschev A, Koitschev C, et al. Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial. J Cyst Fibros. 2014 Jul;13(4):461-70. doi: 10.1016/j.jcf.2014.02.005.
5. Omonova D.R. The importance of aerosol therapy in restoring mucociliary clearance. Journal of Medicine and Practice. 2023.
6. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600.
